ASX:OCCPharmaceuticals, Biotechnology & Life SciencesBiotechnology
Orthocell Ltd
$0.730
$0.010 (1.35%)
Day Range
$0.730 – $0.750
52 Week Range
$0.700 – $1.600
Volume
65.17K
Avg Volume (10D)
155.58K
Market Cap
$198.80M
Price Chart
Market Statistics
Open$0.740
Previous Close$0.740
Day High$0.750
Day Low$0.730
52 Week High$1.600
52 Week Low$0.700
Valuation
Market Cap198.80M
Shares Outstanding272.33M
Price to Book4.88
Trading Activity
Volume65.17K
Value Traded47.93K
Bid$0.730 × 27,396
Ask$0.750 × 16,113
Performance
1 Day1.37%
5 Day4.96%
13 Week-13.45%
52 Week-39.34%
YTD-31.80%
Technical Indicators
RSI (14)47.15
50-Day SMA$0.754
200-Day SMA$0.902
Latest News
Biotechnology
Orthocell Appoints MediTime as Thai Distributor for Remplir Nerve Repair
Orthocell names MediTime exclusive Thai distributor for Remplir nerve repair, taps US$84m market; Thai FDA CY25 approval; $48m cash, no debt.
Biotechnology
Orthocell Secures Access to 221 US Military & VA Medical Centres for Remplir
Orthocell wins access to 221 US DoD/VA centres for Remplir, a major US market expansion as HY26 revenue hits A$6.2m and cash sits at A$49.4m.
Biotechnology
Orthocell's Remplir Device Used in 23 Ukrainian Soldier Surgeries, Validating Field Utility
Orthocell's Remplir validated after 23 Ukrainian surgeries, boosting defence-market traction and global expansion; HY26 revenue +49%, cash ~A$49m.
Biotechnology
Orthocell Appoints Exclusive Remplir Distributor Ahead of UK Rollout
Orthocell names LEDA Orthopaedics exclusive UK distributor for Remplir ahead of regulatory approval, signaling rapid UK rollout and market prep.